By my reckoning, IF the CD19/CF33 CAR-T trial should succeed and cure solid tumour, IMU will way surpass CSL. I have posted before the market size of solid tumour can reach up to US$474bn by 2027. If my maths is correct, even just taking 10% of that is about US$50bn/ year. At a PE of just 20 will give IMU a market cap of US$1 trillion dollar.
I know it is mind blowing, but that is the real potential here. But of course, there is a big IF the trial works.
Media Thread, page-1350
-
- There are more pages in this discussion • 12,894 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $409.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.6¢ | $320.1K | 5.684M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 964369 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 999092 | 24 |
View Market Depth
| Last trade - 13.02pm 19/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |